Wall Street analyst price targets, ratings consensus & upside potential · Updated Feb 28, 2026
Last 12 months price action with 12-month analyst target path
As of February 28, 2026, Chord Energy Corporation (CHRD) has a Wall Street consensus price target of $123.56, based on estimates from 17 covering analysts. With the stock currently trading at $108.37, this represents a potential upside of +14.0%. The company has a market capitalization of $6.15B.
Analyst price targets range from a low of $99.00 to a high of $151.00, representing a 42% spread in expectations. The median target of $119.00 aligns closely with the consensus average.
The current analyst consensus rating is Buy, with 12 analysts rating the stock as a Buy or Strong Buy,3 rating it Hold, and 2 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, CHRD trades at a trailing P/E of 146.4x and forward P/E of 22.6x. Analysts expect EPS to grow -38.4% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $108.37, with bear and bull scenarios of $-2577.32 and $871.60 respectively. Model confidence stands at 32/100, suggesting limited visibility into future performance.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationSee how CHRD stacks up against sector leader California Resources Corporation.
Start ComparisonChord Energy Corporation (CHRD) has a consensus 12-month price target of $123.56, implying 14.0% upside from $108.37. The 17 analysts covering CHRD see moderate appreciation potential.
CHRD has a consensus rating of "Buy" based on 17 Wall Street analysts. The rating breakdown is predominantly bullish, with 12 Buy/Strong Buy ratings. The consensus 12-month price target of $123.56 implies 14.0% upside from current levels.
CHRD trades at a forward P/E of 22.6039x, representing a moderate valuation. With analysts targeting $123.56 (14.0% implied move), the stock appears reasonably valued with upside.
The most bullish Wall Street analyst has a price target of $151 for CHRD, while the most conservative target is $99. The consensus of $123.56 represents the median expectation. Our quantitative valuation model projects a bull case target of $872 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
CHRD is well covered by analysts, with 17 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 12 have Buy ratings, 3 recommend Hold, and 2 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month CHRD stock forecast based on 17 Wall Street analysts shows a consensus price target of $123.56, with estimates ranging from $99 (bear case) to $151 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $108, with bear/bull scenarios of $-2577/$872.
Our quantitative valuation model calculates CHRD's fair value at $108 (base case), with a bear case of $-2577 and bull case of $872. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 32/100.
CHRD trades at a forward P/E ratio of 22.6x based on next-twelve-months earnings estimates compared to a trailing P/E of 146.4x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are optimistic on CHRD, with a "Buy" consensus rating and $123.56 price target (14.0% upside). 12 of 17 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
CHRD analyst price targets range from $99 to $151, a 42% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $123.56 consensus represents the middle ground. Our model's $-2577-$872 range provides an independent fundamental perspective.